Sbir phase 2 topic 314

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500054C
Awardee
Awarding agency
Obligated
$299,920

Award facts

Contract value 100% obligated
$299,920.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02142, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $299,920

About this award

The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Phase 2 contract worth $299,920.00 to Akrivis Technologies, LLC, a minority-owned, small disadvantaged business in Cambridge, MA. The contract, which is a definitive, firm-fixed-price contract, supports SBIR Topic 314 and has an ultimate completion date of October 21, 2016. The contract is set aside for total small business participation.

Quick answers

Who was awarded contract HHSN261201500054C?

HHSN261201500054C was awarded to Akrivis Technologies, LLC by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500054C worth?

The government has obligated $299,920 on HHSN261201500054C.

Was contract HHSN261201500054C competed?

The extent of competition for HHSN261201500054C was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award